Chinese Journal of Pharmaceuticals
|
2026, 57(4): 494-498
• Pharmaceutical Management & Information •
Feasibility Study on Rare Disease Sector as a Strategic Pivot for Innovative Drug Development in China from the Perspective of Industrial Management
Full
Jianhui LIU, Yufeng MAO*
Affiliations
- Shanghai Shyndec Pharmaceutical Marketing Co., Ltd., Shanghai 200050
Published: 2026-04-10
doi: 10.16522/j.cnki.cjph.2026.04.017
Outline
刘健惠, 茅喻丰.
产业管理视角下罕见病领域作为中国创新药战略支点的可行性研究.
中国医药工业杂志,
2026
, 57
(4)
: 494
-498
.
DOI: 10.16522/j.cnki.cjph.2026.04.017
Jianhui LIU, Yufeng MAO.
Feasibility Study on Rare Disease Sector as a Strategic Pivot for Innovative Drug Development in China from the Perspective of Industrial Management[J].
Chinese Journal of Pharmaceuticals,
2026
, 57
(4)
: 494
-498
.
DOI: 10.16522/j.cnki.cjph.2026.04.017
Year 2026 volume 57 Issue 4
119
31
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2026.04.017
- Receive Date:2026-03-03
- Online Date:2026-11-05
- Published:2026-04-10